A Double-Blind, Placebo-Controlled Trial Demonstrating the Safety, Tolerability, and Pharmacokinetics of Single, Escalating Oral Doses of RTI-336

by F. Ivy Carroll, Thomas R. Kosten, Jeffrey J. Buda, Laurene Wang, Bradford B. Walters
Published 2018-07-01

Selective κ opioid antagonists nor-BNI, GNTI and JDTic have low affinities for non-opioid receptors and transporters.

by Thomas A Munro, Xi-Ping Huang, Carmela Inglese, Maria Grazia Perrone, Ashlee Van't Veer, F Ivy Carroll, Cécile Béguin, William A Carlezon, Nicola A Colabufo, Bruce M Cohen, Bryan L Roth
Published 2013-01-01

Nanobody-enabled monitoring of kappa opioid receptor states

by Tao Che, Justin English, Brian E. Krumm, Kuglae Kim, Els Pardon, Reid H. J. Olsen, Sheng Wang, Shicheng Zhang, Jeffrey F. Diberto, Noah Sciaky, F. Ivy Carroll, Jan Steyaert, Daniel Wacker, Bryan L. Roth
Published 2020-03-01

Sex Differences in the Effects of a Kappa Opioid Receptor Antagonist in the Forced Swim Test

by Abigail Laman-Maharg, Abigail Laman-Maharg, Alexia V. Williams, Mikaela D. Zufelt, Vanessa A. Minie, Stephanie Ramos-Maciel, Rebecca Hao, Evelyn Ordoñes Sanchez, Tiffany Copeland, Jill L. Silverman, Angelina Leigh, Rodney Snyder, F. Ivy Carroll, Timothy R. Fennell, Brian C. Trainor, Brian C. Trainor
Published 2018-02-01